Cart
sales@molnova.com
(R)-Carisbamate
CAS No. 194085-74-0
(R)-Carisbamate( —— )
Catalog No. M23882 CAS No. 194085-74-0
(R)-Carisbamate is the R-isomer of Carisbamate . Carisbamate is an experimental anticonvulsant drug.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 69 | In Stock |
|
| 2MG | 50 | In Stock |
|
| 5MG | 77 | In Stock |
|
| 10MG | 110 | In Stock |
|
| 25MG | 199 | In Stock |
|
| 50MG | 277 | In Stock |
|
| 100MG | 397 | In Stock |
|
| 200MG | 550 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name(R)-Carisbamate
-
NoteResearch use only, not for human use.
-
Brief Description(R)-Carisbamate is the R-isomer of Carisbamate . Carisbamate is an experimental anticonvulsant drug.
-
Description(R)-Carisbamate is the R-isomer of Carisbamate . Carisbamate is an experimental anticonvulsant drug.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number194085-74-0
-
Formula Weight215.63
-
Molecular FormulaC9H10ClNO3
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESO[C@H](C1=CC=CC=C1Cl)COC(N)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
L-Propargylglycine
L-Propargylglycine is an inhibitor of the enzyme.l-propargylglycine (LPG) irreversibly inhibited the enzyme from Crotalus adamanteus and Crotalus atrox in a dose- and time-dependent manner.?Inactivation was irreversible which was significantly protected by the substrate l-phenylalanine.?
-
AC1NS4RE
SU5614 is a potent and selective FLT3 inhibitor. SU5614 has inhibitory activity for FLT3 and selectively induces growth arrest, apoptosis, and cell cycle arrest in Ba/F3 and AML cell lines expressing a constitutively activated FLT3.
-
TAK-448
TAK-448 (MVT-602) is a potent and full KISS1R agonist with an IC50 of 460 pM and an EC50 of 632 pM.TAK-448 has been used in trials studying the treatment of Prostate Cancer, Low Testosterone, Prostatic Neoplasms, and Hypogonadotropic Hypogonadism.
